Deciphering the genetic interconnection between sarcopenia and osteoporosis: SCD1
- PMID: 40481346
- DOI: 10.1007/s00774-025-01612-z
Deciphering the genetic interconnection between sarcopenia and osteoporosis: SCD1
Abstract
Introduction: Sarcopenia is closely related to osteoporosis, but the causal direction of these associations remains unclear. This study aims to explore these potential causal associations from the perspective of gene regulation.
Materials and methods: Differentially expressed genes between sarcopenia and control, were identified as exposure factors, with osteoporosis serving as outcome variable, to identify key genes that had potential causal association with osteoporosis. Further analysis was conducted to investigate the causal links between key genes and sarcopenia-related characteristics. Moreover, enrichment analyses, ceRNA and Gene-Gene Interaction network were studied.
Results: Only SCD1 demonstrated a potential causal association with osteoporosis (OR = 0.9970, P = 0.0217), acting as a protective factor against the disease. The potential causal links between SCD1 and sarcopenia-related characteristics are executed. SCD1 was identified as a risk factor for low hand grip strength (OR = 1.1397, P = 0.0290), while being pinpointed as a protective factor for appendicular lean mass (OR = 0.8777, P = 0.0147), usual walking pace (OR = 0.9834, P = 0.0290), whole body fat-free mass (OR = 0.9412, P = 0.0227), and trunk fat-free mass (OR = 0.9425, P = 0.0257). All analyses passed Steiger directional test, indicating a unidirectional causal association. Moreover, indicated that SCD1 was significantly associated with metabolic pathways related to lipid biosynthesis and regulation.
Conclusion: SCD1 was identified as a protective factor for osteoporosis and a risk factor for sarcopenia. This research provides new insights for the study of sarcopenia and osteoporosis, and offers theoretical backing for the positive effects of exercise in the elderly.
Keywords: Causal inference; Genetics; Mendelian randomization; Osteoporosis; Sarcopenia.
© 2025. The Japanese Society Bone and Mineral Research.
Conflict of interest statement
Declarations. Conflicting interest: The authors declare that they have no competing interests. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Clinical trial number: Not applicable.
References
-
- Saykali B, Mathiah N, Nahaboo W, Racu ML, Hammou L, Defrance M, Migeotte I (2019) Distinct mesoderm migration phenotypes in extra-embryonic and embryonic regions of the early mouse embryo. Elife 8 https://doi.org/10.7554/eLife.42434
-
- Bettis T, Kim BJ, Hamrick MW (2018) Impact of muscle atrophy on bone metabolism and bone strength: implications for muscle-bone crosstalk with aging and disuse. Osteoporos Int 29:1713–1720. https://doi.org/10.1007/s00198-018-4570-1 - DOI - PubMed - PMC
-
- Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127:990s-s991. https://doi.org/10.1093/jn/127.5.990S . (in English) - DOI - PubMed
-
- Paintin J, Cooper C, Dennison E (2018) Osteosarcopenia. Br J Hospital Med (London, England: 2005) 79:253–258 (in English). https://doi.org/10.12968/hmed.2018.79.5.253
-
- Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31. https://doi.org/10.1093/ageing/afy169 . (in English) - DOI - PubMed
MeSH terms
Substances
Grants and funding
- 82172442/National Natural Science Foundation of China
- 202403AC100003/Social development project of Science and Technology Department of Yunnan Province
- zx2022000101/Yunnan Provincial Center for Clinical Medicine in Spinal and Spinal Cord Disorders
- 202005AG070004/Yunnan Digital Orthopaedic Key Laboratory
- 202102AA310068/Yunnan Orthopedics and Sports Rehabilitation Clinical Medical Research Center
LinkOut - more resources
Full Text Sources
Medical
